adidas AG

  • WKN: A1EWWW
  • ISIN: DE000A1EWWW0
  • Land: Deutschland

Nachricht vom 09.01.2017 | 10:42

adidas AG: Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 2016/1052 / 3rd Tranche - 9th Interim Announcement

adidas AG / Share Buyback

09.01.2017 / 10:42
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Herzogenaurach, January 9, 2017 adidas AG: Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 2016/1052 / 3rd Tranche - 9th Interim Announcement In the period from January 2, 2017 up to and including January 6, 2017, adidas AG bought back a total of 107,077 shares of adidas AG within the framework of the share buyback programme. In the announcement of November 7, 2016 pursuant to Art. 2 Sec. 1 of the Commission Delegated Regulation (EU) 2016/1052 it was communicated that the repurchase of treasury shares within the framework of a third tranche would commence on November 8, 2016. The overall volume of the shares bought back daily in the period from January 2, 2017 up to and including January 6, 2017 and the daily volume- weighted average stock market prices of the shares are as follows:

Date                  Overall volume of      Volume-weighted average
                      shares bought back     stock market price (EUR)1)
                      (number)
January 2, 2017       20,900                 151.2606
January 3, 2017       21,002                 149.7938
January 4, 2017       21,439                 147.3859
January 5, 2017       21,900                 144.8434
January 6, 2017       21,836                 144.4592
In total              107,077                147.4977


1) Excluding incidental purchasing costs, rounded to four places according to commercial practice The total number of shares which have been bought back so far by adidas AG since November 8, 2016 within the framework of the third tranche of the share buyback programme thus amounts to 1,762,311 shares. The total number of shares which have been bought back so far by adidas AG within the framework of the share buyback programme resolved upon on October 1, 2014 and initiated on November 7, 2014 (including the shares bought back within the framework of the third tranche) thus amounts to 10,781,080 shares. Further information pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under http://www.adidas-group.com/s/sharebuyback. The purchase of the adidas AG shares was carried out by a bank assigned by adidas AG and exclusively via the Frankfurt Stock Exchange (XETRA trading). Herzogenaurach, January 9, 2017 adidas AG The Executive Board
09.01.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: adidas AG Adi-Dassler-Straße 1 91074 Herzogenaurach Germany Internet: www.adidas-group.com End of News DGAP News Service

News im Fokus

IRprint: Nachhaltiger Eindruck durch einen professionellen Ausdruck

Das Team von IRprint bietet für geschäftliche Dokumente einen persönlichen Service mit langjähriger Finanzmarktexpertise – angefangen bei der Erstellung von Textinhalten bis hin zum professionellen Druck sowohl im Digital- als auch Offsetdruckverfahren.

Nutzen Sie unser Knowhow in der Kapitalmarktkommunikation und unsere exklusive Kooperation mit CEWE, Europas Marktführer im Bereich Fotoservice mit herausragender Expertise im kommerziellen Online-Druck. So gelingt Ihnen sowohl inhaltlich als auch optisch ein glänzender Auftritt.

GBC im Fokus

SYGNIS AG will mit Innova-Übernahme Synergieeffekte heben

Die SYGNIS AG plant, mit den aktuellen Kapitalerhöhungen (bis zu 10 Mio. €) den Erwerb der Innova Biosciences Ltd. zu finanzieren, eines Spezialisten aus dem Bereich der Proteinmarkierung. Mit dem Erwerb des profitablen Unternehmens sollen Synergieeffekte gehoben, der Workflow erweitert und darüber hinaus die operativen Kennzahlen verbessert werden. Sowohl im Peer-Group-Vergleich als auch innerhalb eines DCF-Bewertungsmodells stufen wir den Kaufpreis als sehr attraktiv ein.

Aktueller Webcast

Douglas Holding AG

6M Interim Financial Results

24. Mai 2017

Aktuelle Research-Studie

Original-Research: FinTech Group AG (von GBC AG): BUY FinTech Group AG

29. Mai 2017